Analytical Data
-
Gene name
THSD7A
- Application
-
Alternative Names
THSD7A；KIAA0960；Thrombospondin type-1 domain-containing Protein 7A
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q9UPZ6
-
Expression Region
全长
-
AA Sequence
full
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
THSD7A, or Thrombospondin Type-1 Domain-Containing Protein 7A, is a member of the thrombospondin-related protein family that has garnered attention in recent years due to its implicated role in various biological processes, including cell adhesion, migration, and angiogenesis. The protein is particularly significant in the context of several diseases, including cancer, where it may facilitate tumor progression and metastasis. Research has shown that THSD7A acts as a potential biomarker for specific cancers, especially in cancer diagnosis and prognosis, making it a focal point for therapeutic strategies. Additionally, its expression patterns have been linked to various physiological conditions and diseases, pointing to its potential as a target for drug development. Studies also delve into the structural aspects of the THSD7A protein, emphasizing its unique domains and their functional implications in cellular activities. Given its multifaceted roles, the recombinant expression of THSD7A provides a valuable tool for understanding its function and interactions at the molecular level, paving the way for novel therapeutic interventions in diseases where THSD7A is involved. Expanding our knowledge of THSD7A through various research methodologies, including protein assays and in vivo studies, is crucial for elucidating the therapeutic potential and clinical relevance of this protein in modern medicine.
